Search

An editorial is presented which discusses the benefits of photobiomodulation therapy (PBMT) for Duchenne muscular dystrophy (DMD), a rare genetic disease characterized by muscle weakness and wasting. PBMT, which involves the use of red/near-infrared light to stimulate mitochondria, and could have multiple positive effects on DMD. The author suggests that further research and clinical trials should be conducted to explore the use of PBMT as a potential treatment for DMD.

An editorial is presented on discovery of biophotons attributed to Alexander Gurwitsch working in the Soviet Union in the 1920s. Topics include biophotons arising from excited state chemical intermediates or reaction products generated within cells; and attempts being made to demonstrate quantum coherence in biophoton emission.

The author reflects on the potential causes and treatments of Gulf War Illness (GWI) that affects mainly veterans in the U.S. and United Kingdom. Topics include the symptoms of GWI like headaches, cognitive impairment, and gastrointestinal disturbance, studies on the possible GWI causes like exposure to acetylcholinesterase inhibitor neurotoxins, and potential treatments like mindfulness-based stress reduction and cognitive behavioral therapy.

The article focuses on Autism that is a neurodevelopmental disorder that is often diagnosed in children within the first 3 years of life and it affects four to five times more boys than girls. Topics include examines the causes of ASD are multifactorial as there is a genetic basis as siblings of affected children are several times more likely to be autistic than the general population.

An editorial is presented on photobiomodulation therapy (PBMT) not becoming a mainstream medical therapy. Topics include hundreds of successful clinical studies and widespread use as an alternative and complementary medicine treatment; and Mitochondria containing a variety of different cytochromes either as part of functional proteins or as electron transport shuttles (cytochrome c).

The article provides information on photobiomodulation therapy (PBMT) for skin pigmentation disorders. Topics discussed include the main evolutionary purpose of skin pigmentation, treatments that have been tested for vitiligo, and a study by C. T. Oh and colleagues on how PBMT might reduce melanin production in the skin.

An editorial is presented on the potential benefits of incorporating infrared radiation (IR) into indoor lighting systems. It highlights the shift from traditional incandescent light bulbs to fluorescent tubes and LED (Light Emitting Diode) lighting for energy efficiency purposes. It further explores whether the absence of IR exposure in modern lifestyles could contribute to various health conditions and diseases.

The article offers information on mitochondrial transplantation focuses on isolation of mitochondria from cells, which had developed resistance to cytotoxic antibiotics, and when these mitochondria were incubated with antibiotic-sensitive cells, the resistance was transferred, suggesting that the mitochondria had been taken up by the recipient cells by a process of endocytosis.

The article offers information on the history, causes, and treatment options for epilepsy, a chronic seizure disorder affecting millions of people worldwide. Topics include causes of seizures which are due to abnormal neuronal firing in the brain, which can be attributed to brain damage, genetic causes, or reflex epilepsy triggered by various stimuli; how drug treatments have been developed; and the exploration of alternative therapies such as the ketogenic diet and photobiomodulation therapy.

An editorial is presented which discusses risk of chemotherapy drugs causing severe tissue damage and injury if they are accidentally introduced into tissue during infusion or injection. Anthracyclines are the worst offenders, but a new treatment called Totect has been approved for the prevention of anthracycline extravasation injury by chelating free iron ions, inhibiting the redox cycling reaction, and reducing tissue necrosis.

Background: Musculoskeletal disorders caused by osteoarthritis (MSDs/OA) are a growing problem in the modern industrialized society in Canada. Overall aging of the general population and a progressive lack of exercise contribute to this alarming increase. Moreover, a range of chronic conditions including cardiovascular and mental diseases show significantly higher comorbidity with MSDs/OA. Conventional medical treatment for MSDs/OA includes nonsteroidal anti-inflammatory drugs and opiate pain killers. These drugs have major drawbacks such as a relative lack of efficacy, potential for addiction, and even death (Vioxx scandal). Photobiomodulation (PBM) was discovered over 50 years ago but has still not attained widespread acceptance by the medical community. This is partly due to uncertainty about the precise molecular mechanisms of action and a bewildering array of different wavelengths and dosimetric parameters employed in reported studies. Objective: The goal of this review was to survey literature reports of PBM, also known as low-level laser therapy used for treatment of MSDs/OA, concentrating on the growth over time, different wavelengths employed, and application to different joints. Methods: We searched the PubMed database for publication of study on PBM to treat the most common joints. Results: We show that the field of PBM to treat MSDs/OA is expanding exponentially over the past 20 years. A trend has emerged over time for more power to achieve better effective treatments, and the understanding of the physiological effect of safe parameters has improved. There is, however, no consensus on the best set of parameters to treat a specific patient indication. Conclusions: Finally, we highlight gaps in our knowledge and the barriers to further clinical trials. We suggest that the growing body of evidence indicating efficacy, and the almost total lack of side effects, should encourage continued clinical research to support clinical applications where better rehabilitation treatments are much needed. [ABSTRACT FROM AUTHOR]

The author reflects on the role of polarized light in photobiomodulation (PBM), which is used to treat various medical diseases and disorders. Also cited are a comparison of the use of light-emitting diodes (LED) and fluorescent light energy (FLE) in PBM, and the effectiveness of the FLE method for treating conditions like rosacea, burns, solar lentigenes, and wound healing.

The article presents the discussion on approach for improving overall health especially cardiovascular health and extending the lifespan. Topics include mechanism of action of saunas being based on the concept of hormesis; and proposed to be nonradiative energy transmission between adjacent water molecules deep into the tissue.

The article focuses on the need for Caution when applying Photobiomodulation Therapy (PBMT) for Hereditary Diseases. Topic include the effect of PBMT in an animal model of Meckel syndrome (MKS), involve Meckel (or Meckel–Gruber) syndrome is a rare type of genetic Polycystic Kidney Disease (PKD) that has effects on the central nervous system and liver.